Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity

British Journal of Pharmacology

Volumn 158, Issue 3, 2009, Pages 771-778

  Stucchi, Paula ^a   Cano, Victoria ^b   Ruiz Gayo, Mariano ^b   Fernández Alfonso, María S ^a  

^a INSTITUTO PLURIDISCIPLINAR   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Adipose tissue; Aliskiren; Angiotensin II; Diet induced obesity; Direct renin inhibition; Leptin; Renin angiotensin system

Indexed keywords

ALISKIREN; ANGIOTENSIN I; ANGIOTENSIN II; LEPTIN; RENIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DOWN REGULATION; FOOD INTAKE; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; OSMOTIC MINIPUMP; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADIPOSITY; AMIDES; ANIMALS; DIETARY FATS; EATING; ENERGY INTAKE; FUMARATES; LEPTIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; RENIN; RENIN-ANGIOTENSIN SYSTEM; WEIGHT GAIN;

EID: 70350057468     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00355.x     Document Type: Article

References (33)

1. Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H (2006). Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 48 : 51 57.
2. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M et al. (2004). Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension 43 : 993 1002.
3. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA (2004). Activation of the systemic and adipose rennin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol 287 : 943 949.
4. Cassis LA, Lynch KR, Peach MJ (1988). Localization of angiotensinogen messenger RNA in rat aorta. Circ Res 62 : 1259 1262.
5. Cassis LA, English VL, Bharadwaj K, Boustany CM (2004). Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 145 : 169 174.
6. Darimont C, Vassaux G, Ailhaud G, Negrel R (1994). Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 135 : 2030 2036.
7. Derkx FHM, van der Meiracker AH, Fischli W, Admiraal PJJ, Man in't Veld AJ, van Brummelen P et al. (1991). Nonparallell effects of rennin inhibitor treatment on plasma rennin activity and angiotensins I and II in hypertensive subjects. An assay-related artefact. Am J Hypertens 4 : 602 609.
8. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM (1999). Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 17 : 555 560.
9. Engeli S, Schling P, Gorzelniak K, Boschman M, Janke J, Ailhaud G et al. (2003). The adipose tissue rennin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35 : 807 825.
10. Gálvez-Prieto B, Bolbrinker J, Stucchi P, de Las Heras AI, Merino B, Arribas S et al. (2008). Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol 197 : 55 64.
11. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM (2002). Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 20 : 965 973.
12. Harp JB, DiGirolamo M (1995). Components of the renin-angiotensin system in adipose tissue: changes with maturation and adipose mass enlargement. J Gerontol A Biol Sci Med Sci 50 : 270 276.
13. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM (2002). Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51 : 1699 1707.
14. Jones BH, Standridge MK, Taylor JW, Moustaid N (1997). Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 273 : 236 242.
15. Jordan J, Engeli S, Boye SW, Le Breton S, Keefe DL (2007). Direct Renin inhibition with aliskiren in obese patients with arterial hypertension. Hypertension 49 : 1047 1055.
16. Kim S, Whelan J, Claycombe K, Reath DB, Moustaid-Moussa N (2002). Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. J Nutr 132 : 1135 1140.
17. Kim S, Soltani-Bejnood M, Quignard-Boulange A, Massiera F, Teboul M, Ailhaud G et al. (2006). The adipose Renin-Angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal Renin-Angiotensin system. J Biomed Biotechnol 2006 : 27012.
18. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M et al. (2005). Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146 : 3481 3489.
19. Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M et al. (2008). Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. Eur J Pharmacol 588 : 316 324.
20. Lafontan M (2005). Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 45 : 119 146.
21. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM et al. (2001). Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15 : 2727 2729.
22. Paul M, Mehr AP, Kreutz R (2006). Physiology of the renin-angotensin systems. Physiol Rev 86 : 747 803.
23. Phillips MI, Speakman EA, Kimura B (1993). Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43 : 1 20.
24. Poulsen K, Jorgenssen J (1974). An easy radioimmunological microassay of rennin activity, concentreation asnd substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 39 : 816.
25. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R (2001). Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 142 : 487 492.
26. Somoza B, Guzmán R, Cano V, Merino B, Ramos P, Díez-Fernández C et al. (2007). Induction of cardiac uncoupling protein-2 expression and adenosine 5′-monophosphate-activated protein kinase phosphorylation during early states of diet-induced obesity in mice. Endocrinology 148 : 924 931.
27. Staessen JA, Li Y, Richart T (2006). Oral renin inhibitors. Lancet 368 : 1449 1456. Erratum in: Lancet. 2006 Dec 16; 368 (9553): 2124.
28. Takahashi N, Li F, Hua K, Deng J, Wang CH, Bowers RR et al. (2007). Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 6 : 506 512.
29. Tschöp MH, Hui DY, Horvath TL (2007). Diet-induced leptin resistance: the heart of the matter. Endocrinology 148 : 921 923.
30. Unger RH (2003). Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144 : 5159 5165.
31. Wood JM, Maibaum J, Rahuel J, Grütter MG, Cohen NC, Rasetti V et al. (2003). Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun 308 : 698 705.
32. Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P et al. (2005). Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54 : 991 999.
33. Zanchi A, Dulloo AG, Perregaux C, Montani JP, Burnier M (2007). Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties. Am J Physiol Endocrinol Metab 293 : E91 E95.